TCL Archive In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute October 31, 2014
TCL Archive NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign December 17, 1999
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years October 7, 1977
